FDA Fights Back Against ViroPharma's Generic Vancocin Suit
ViroPharma Inc. doesn't deserve three more years of exclusive rights for its Vancocin, the U.S. Food and Drug Administration told a Washington federal judge Tuesday in a motion to dismiss a...To view the full article, register now.
Already a subscriber? Click here to view full article